BlackRock Advisors’s Microbot Medical MBOT Stock Holding History

BlackRock Advisors’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1K	Hold	16	–	–	﹤0.01%	3694
2016 Q3	$3K	Hold	16	–	–	﹤0.01%	3674
2016 Q2	$1K	Hold	16	–	–	﹤0.01%	3739
2016 Q1	$7K	Hold	16	–	–	﹤0.01%	3624
2015 Q4	$11K	Hold	16	–	–	﹤0.01%	3613
2015 Q3	$11K	Hold	16	–	–	﹤0.01%	3642
2015 Q2	$14K	Buy	16 +4	+33%	+$4.71K	﹤0.01%	3574
2015 Q1	$20K	Hold	12	–	–	﹤0.01%	3456
2014 Q4	$18K	Hold	12	–	–	﹤0.01%	3530
2014 Q3	$25K	Hold	12	–	–	﹤0.01%	3448
2014 Q2	$40K	Hold	12	–	–	﹤0.01%	3292
2014 Q1	$26K	Buy	12 +4	+50%	+$9.57K	﹤0.01%	3360
2013 Q4	$17K	Buy	8 +2	+33%	+$4.23K	﹤0.01%	3422
2013 Q3	$18K	Hold	6	–	–	﹤0.01%	3335
2013 Q2	$17K	Buy	+6	New	+$16.9K	﹤0.01%	3298

Other funds holding MBOT

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 27.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DSC

Duncker Streett & Co St. Louis, Missouri $591M AUM 26.48% 1-Year Est. Return

BlackRock Advisors's MBOT Position: Q4 2016 in Review

BlackRock Advisors held its Microbot Medical (MBOT) position steady in Q4 2016 at 16 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #3694.

BlackRock Advisors first reported a position in MBOT in Q2 2013 and has held it in 15 quarters since. The position peaked at $40K in Q2 2014. 18 funds tracked by Wall St. Rank hold MBOT as of Q4 2016.

BlackRock Advisors held 16 shares of Microbot Medical worth $1K as of Q4 2016.
BlackRock Advisors left its Microbot Medical share count unchanged in Q4 2016.
Microbot Medical made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3694 holding.
BlackRock Advisors first reported a position in Microbot Medical in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Microbot Medical position peaked at $40K in Q2 2014.
18 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.